*The chief investigative committee of the U.S. House of Representatives announced last week that it will be looking into pharmaceutical giant Pfizer’s alleged targeting of African American transplant patients for off-label use of the controversial drug Rapamune.
The investigation was prompted by Congressional Black Caucus member Edophus Towns of New York who said Pfizer placed Black patients at risk and compared the Rapamune controversy to the infamous Tuskegee syphilis experiment.
Pfizer’s targeting of Blacks with the drug came to light last month when the details of a lawsuit filed against the company were unsealed.
Pfizer allegedly targeted transplant centers used primarily by African Americans. The lawsuit and Congressman Towns charge that the lives of Black patients “were placed at serious risk for life threatening ailments.”
Meanwhile, Pfizer counters that it did not target Blacks because the controversial drug was used in “a broad range of patients.” (source: Taylor Media Services)